These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34160771)

  • 21. Immunotherapeutic targeting of surfaceome heterogeneity in AML.
    Bordeleau ME; Audemard É; Métois A; Theret L; Lisi V; Farah A; Spinella JF; Chagraoui J; Moujaber O; Aubert L; Khakipoor B; Mallinger L; Boivin I; Mayotte N; Hajmirza A; Bonneil É; Béliveau F; Pfammatter S; Feghaly A; Boucher G; Gendron P; Thibault P; Barabé F; Lemieux S; Richard-Carpentier G; Hébert J; Lavallée VP; Roux PP; Sauvageau G
    Cell Rep; 2024 Jun; 43(6):114260. PubMed ID: 38838225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune escape and immunotherapy of acute myeloid leukemia.
    Vago L; Gojo I
    J Clin Invest; 2020 Apr; 130(4):1552-1564. PubMed ID: 32235097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting acute myeloid leukemia through multimodal immunotherapeutic approaches.
    Przespolewski AC; Portwood S; Wang ES
    Leuk Lymphoma; 2022 Apr; 63(4):918-927. PubMed ID: 34818963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental approaches in immunological control of acute myelogenous leukaemia.
    Torelli GF; Orsini E; Guarini A; Kell J; Foà R
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):189-209. PubMed ID: 11355931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic stem cell transplantation and immunotherapy for pediatric acute myeloid leukemia: an open challenge.
    Lucchini G; Bader P
    Expert Rev Hematol; 2014 Apr; 7(2):291-300. PubMed ID: 24617334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia.
    Sinha C; Cunningham LC
    Pediatr Blood Cancer; 2016 Dec; 63(12):2078-2085. PubMed ID: 27535002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
    Bonifant CL; Szoor A; Torres D; Joseph N; Velasquez MP; Iwahori K; Gaikwad A; Nguyen P; Arber C; Song XT; Redell M; Gottschalk S
    Mol Ther; 2016 Sep; 24(9):1615-26. PubMed ID: 27401038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
    Cheuk AT; Guinn BA
    Front Biosci; 2008 Jan; 13():2022-9. PubMed ID: 17981688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approaches for the immunotherapy of acute myeloid leukemia.
    Geiger TL; Rubnitz JE
    Discov Med; 2015 Apr; 19(105):275-84. PubMed ID: 25977190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive transfer of T cells transduced with a chimeric antigen receptor to treat relapsed or refractory acute leukemia: efficacy and feasibility of immunotherapy approaches.
    Ding G; Chen H
    Sci China Life Sci; 2016 Jul; 59(7):673-7. PubMed ID: 27142351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute myeloid leukaemia and the immune system: implications for immunotherapy.
    Barrett AJ
    Br J Haematol; 2020 Jan; 188(1):147-158. PubMed ID: 31782805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
    Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myeloid leukemia stem cells and CD33-targeted immunotherapy.
    Walter RB; Appelbaum FR; Estey EH; Bernstein ID
    Blood; 2012 Jun; 119(26):6198-208. PubMed ID: 22286199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging strategies for high-risk and relapsed/refractory acute myeloid leukemia: novel agents and approaches currently in clinical trials.
    Sasine JP; Schiller GJ
    Blood Rev; 2015 Jan; 29(1):1-9. PubMed ID: 25441922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reaserch Advances in Immunotherapy for Acute Myeloid Leukemia--Review].
    Chen ZH; Li YY; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2089-2092. PubMed ID: 33283747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other Treatments.
    Leufven E; Bruserud Ø
    Curr Med Chem; 2019; 26(28):5244-5261. PubMed ID: 30907305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation.
    Rettinger E; Willasch AM; Kreyenberg H; Borkhardt A; Holter W; Kremens B; Strahm B; Woessmann W; Mauz-Koerholz C; Gruhn B; Burdach S; Albert MH; Schlegel PG; Klingebiel T; Bader P
    Blood; 2011 Nov; 118(20):5681-8. PubMed ID: 21948300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide vaccines for patients with acute myeloid leukemia.
    Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A
    Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges.
    Alfayez M; Borthakur G
    Expert Rev Hematol; 2018 May; 11(5):373-389. PubMed ID: 29589969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.
    Anguille S; Van Tendeloo VF; Berneman ZN
    Leukemia; 2012 Oct; 26(10):2186-96. PubMed ID: 22652755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.